h1 IMF Videos From our weekly educational videos with leading myeloma experts to comprehensive news from key medical cancer conferences around the world, IMF videos are your all-access ticket to critical myeloma research, patient education, and guidance. TV Blog Categories All Content About the IMF ASCO/EHA ASH Ask Dr. Durie Black Swan Research Initiative Community Conversations Community Workshops Emerging Therapies Facebook Live Health Equity IMF History IMWG Inspirational Living Well with Myeloma M-POWER Myeloma in a Minute Myeloma Made Simple Myeloma University NLB Webcasts Patient & Family Webinar Q&A Recent News and Developments Treatments Trending Searches in Myeloma Search by text Per page 6122448 Sort Oldest firstNewest firstRelevanceA-ZZ-A ASH Feb 22, 2024 Real World Outcomes with Idecabtagene Vicleucel (Ide-Cel) CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Ask Dr. Durie Feb 20, 2024 Is the face of myeloma changing? ASH Feb 15, 2024 Early Safety Results of P-BCMA-ALLO1, a Fully Allogeneic Chimeric Antigen Receptor T-Cell (CAR-T), in Patients with Relapsed / Refractory Multiple Myeloma (RRMM) ASH Feb 15, 2024 Treatment Outcomes and Prognostic Factors with Lenalidomide, Bortezomib, and Dexamethasone (RVd) Alone Versus Rvd Plus Autologous Stem Cell Transplantation (ASCT) in African American (AA) Patients with Newly Diagnosed Myeloma in the Determination Trial ASH Feb 15, 2024 Mezigdomide (MEZI) Plus Dexamethasone (DEX) and Daratumumab (DARA) or Elotuzumab (ELO) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Results from the CC-92480-MM-002 Trial Health Equity Feb 9, 2024 PSA 2 | Ice-T Sets the Record Straight On Multiple Myeloma, It's Not Melanoma Pagination First page « First Previous page ‹ Previous … Page 34 Current page 35 Page 36 Page 37 … Next page Next › Last page Last »
